Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01033266 · ClinicalTrials.gov registry record
Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 12
- Enrollment target
NCT01033266 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 12 participants.
The verdict
NCT01033266 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Nasal CPAP will improve cardiopulmonary exercise test (CPET) performance in patients with overlap syndrome(COPD and OSA). Nasal CPAP is proven to improve cardiopulmonary exercise testing in patients with OSA. The investigators hypothesis is that patients with overlap syndrome will have a greater improvement in their cardiopulmonary exercise testing besides a possible improvement in their lung function test and airway resistance.
Interventions
- DIAGNOSTIC_TEST CPET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-02-01 |
| Est. Completion | 2014-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01033266
The ClinicalTrials.gov registry entry for NCT01033266 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CPET is the first listed.
NCT01033266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01033266 about?
NCT01033266 is a clinical study titled "Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome". Nasal CPAP will improve cardiopulmonary exercise test (CPET) performance in patients with overlap syndrome(COPD and OSA). Nasal CPAP is proven to improve cardiopulmonary exercise testing in patients with OSA. The investigators hypothesis is that patients with overlap syndrome will have a greater imp...
What is the current status of trial NCT01033266?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2009-02-01. Estimated completion is 2014-02-28.
What interventions are being tested in trial NCT01033266?
The interventions under investigation include: CPET (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01033266?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.